Evidence-based assessment of safety and mechanistic questions Related to mRNA COVID-19 Vaccines
A 69-year-old woman with dermatopathic lymphadenopathy and hypercalcemia after COVID-19 infection
Dysregulated NK-cell gene expression defines the enduring symptoms of long COVID-19
Analysis of Long COVID characteristics and risk factors in individuals infected with COVID-19
COVID-19 associated mucormycosis and their therapeutics
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients
Pustular psoriasis flare following COVID-19 infection – a case report and literature review
Social inequalities in the misbelief of chloroquine’s protective effect against COVID-19
Covid vaccines are not linked to sudden death in healthy younger adults, study finds
The risk of kidney disease increases following SARS-CoV-2 infection compared to influenza


